Wegener's granulomatosis with dural involvement as the initial clinical manifestation

Internal Medicine

Volumn 36, Issue 7, 1997, Pages 514-518

  Shiotani, Akiko ^a   Mukobayashi, Chizu ^a   Oohata, Hiroshi ^a   Yamanishi, Tetsuzi ^a   Hara, Takeshi ^a   Itoh, Hidekazu ^a   Nishioka, Shingo ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Circulating antineutrophil cytoplasmic antibodies (c ANCA); Cranial magnetic resonance imaging (MRI); Nasal biopsy

Indexed keywords

ANTIBIOTIC AGENT; AUTOANTIBODY; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ADULT; ANTIBODY TITER; ARTICLE; CASE REPORT; CHRONIC SINUSITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DISEASE COURSE; HEADACHE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; NEEDLE BIOPSY; NOSE POLYP; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; SUBDURAL EMPYEMA; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0030852915     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.514     Document Type: Article

References (15)

1. Drachman DA. Neurological complications of Wegener's granulomatosis. Arch Neural 8: 145, 1963.
2. Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 33: 4, 1993.
3. Huffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 116: 488, 1992.
4. Nolle B, Specks U, Luedemann J, Rohrbach MS, DeRemee RA, Gross WL. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med 111: 28, 1989.
5. Savage COS, Winearls CG, Jones S, Marshall PD, Lockwood CM. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet i: 1389, 1987.
6. Kerr GS, Fleisher TA, Hallahan CW, Leavitt RT, Fauci AS, Hoffman GS. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 36: 365, 1993.
7. Ewert BH, Jennette JC, Falk RJ. Antimyeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int 41: 375, 1992.
8. Mayet W-J, Csernok E, Szymkowiak C, Gross WL, Buschenfelde K-HM. Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood 82: 1221, 1993.
9. Cohen Tervaert JW, Huitem MG, Hene RJ, Sluiter WJ. Prevention of relapses in Wegener's granulomatosis by treatment based on anti-neutrophil cytoplasmic antibody titer. Lancet 336: 709, 1990.
10. Rao JK, Allen NB, Feussner JR, Weinberger M. A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis. Lancet 346: 926, 1995.
11. Del Buono EA, Flint A. Diagnostic usefulness of nasal biopsy in Wegener's granulomatosis. Hum Pathol 22: 107, 1991.
12. Marcet JV, Spiera H. Treatment of Wegener's granulomatosis with sulfamethoxazole-trimethoprim. Arch Intern Med 151: 1649, 1991.
13. Hoffman GS, Leavitt RY, Fleisher TA, Minor JR, Fauci AS. Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med 89: 403, 1990.
14. Hoffman GS,Leavitt RY, Kerr GS, Fauci AS. The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum 35: 6112, 1992.
15. Jayne DRW, Esnault VLM, Lockwood CM. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin. J Autoimmunity 6: 207, 1993.